Jun 08, 2023 / 05:30PM GMT
Matthew Charles Taylor - Jefferies LLC, Research Division - Equity Analyst
Okay. We're ready to get started here with our next session. I'm really pleased to be joined by the management team from Tandem. And I'm Matt Taylor, the U.S. medical supplies and devices analyst here at Jefferies. I just want to introduce the team. John Sheridan is the President and CEO; and Leigh Vosseller is the CFO. So we're meant to have about a 25-minute Q&A session that I'll drive via a fireside chat, and then maybe we'll have a couple of minutes at the end if the audience has any questions.
Questions and Answers:
Matthew Charles Taylor - Jefferies LLC, Research Division - Equity AnalystSo I'll give you my first question here from the podium and then joining there in the green room. But I always like to start high level. So maybe stepping back, talking about the insulin pump market. It's been growing nicely in the past few years and really driven by a lot of advances in the technology, not only of the pumps, but of the enabling tech, whether it's CGMs or software. But I
Trustpilot
